Page last updated: 2024-09-05

deflazacort and Low Bone Density

deflazacort has been researched along with Low Bone Density in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Devogelaer, JP; Gennari, C	1
Belmatoug, N; Cacoub, P; Chemlal, K; Cohen, P; De Gennes, C; Khalifa, P; Piette, JC; Verdoncq, B; Wechsler, B; Ziza, JM	1
Balsan, S; Bourdeau, A; Grimberg, R; Lenoir, G; Stéru, D	1

Trials

1 trial(s) available for deflazacort and Low Bone Density

Article	Year
Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss. The Journal of rheumatology, 2001, Volume: 28, Issue:11 Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcium; Double-Blind Method; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prednisone; Pregnenediones; Prospective Studies; Spinal Fractures; Treatment Outcome; Vitamin D	2001

Article

Year

Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.

The Journal of rheumatology, 2001, Volume: 28, Issue:11

Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcium; Double-Blind Method; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prednisone; Pregnenediones; Prospective Studies; Spinal Fractures; Treatment Outcome; Vitamin D

2001

Other Studies

2 other study(ies) available for deflazacort and Low Bone Density

Article	Year
Deflazacort in giant cell arteritis. The Journal of rheumatology, 2002, Volume: 29, Issue:10 Topics: Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcifediol; Dietary Supplements; Dose-Response Relationship, Drug; Giant Cell Arteritis; Humans; Prednisone; Pregnenediones; Randomized Controlled Trials as Topic	2002
Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth. Calcified tissue international, 1987, Volume: 40, Issue:6 Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Body Height; Bone and Bones; Bone Diseases, Metabolic; Calcifediol; Calcium; Child; Child, Preschool; Female; Growth Disorders; Humans; Kidney Diseases; Male; Minerals; Parathyroid Hormone; Prednisone; Pregnenediones	1987

Article

Year

Deflazacort in giant cell arteritis.

The Journal of rheumatology, 2002, Volume: 29, Issue:10

Topics: Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcifediol; Dietary Supplements; Dose-Response Relationship, Drug; Giant Cell Arteritis; Humans; Prednisone; Pregnenediones; Randomized Controlled Trials as Topic

2002

Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.

Calcified tissue international, 1987, Volume: 40, Issue:6

Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Body Height; Bone and Bones; Bone Diseases, Metabolic; Calcifediol; Calcium; Child; Child, Preschool; Female; Growth Disorders; Humans; Kidney Diseases; Male; Minerals; Parathyroid Hormone; Prednisone; Pregnenediones

1987